Home/Filings/4/0001209191-21-028325
4//SEC Filing

Garfield Greg Shaw 4

Accession 0001209191-21-028325

CIK 0001528287other

Filed

Apr 25, 8:00 PM ET

Accepted

Apr 26, 5:17 PM ET

Size

16.6 KB

Accession

0001209191-21-028325

Insider Transaction Report

Form 4
Period: 2021-04-26
Transactions
  • Conversion

    Common Stock

    2021-04-26+5,595,4935,614,384 total(indirect: See Footnote)
  • Conversion

    Series A' Preferred Stock

    2021-04-26323,5910 total(indirect: See Footnote)
    Exercise: $0.00Common Stock (324,450 underlying)
  • Conversion

    Series A' Preferred Stock

    2021-04-268590 total(indirect: See Footnote)
    Exercise: $0.00Common Stock (859 underlying)
  • Conversion

    Series B' Preferred Stock

    2021-04-2618,0320 total(indirect: See Footnote)
    Exercise: $0.00Common Stock (18,032 underlying)
  • Conversion

    Series B' Preferred Stock

    2021-04-265,271,9020 total(indirect: See Footnote)
    Exercise: $0.00Common Stock (5,271,902 underlying)
  • Conversion

    Common Stock

    2021-04-26+18,89118,891 total(indirect: See Footnote)
Footnotes (3)
  • [F1]Shares are held by the Greg and Dori Garfield Living Revocable Trust.
  • [F2]KCK Ltd. has sole voting and investment power with respect to the shares. The board of directors of KCK Ltd., consisting of Antoine Sacy, Kamal Kassar, and Nael Karim Kassar, has delegated its authority to vote or invest the shares to Nael Karim Kassar. As such, Nael Karim Kassar may also be deemed to have sole voting and investment with respect to the shares. Mr. Kassar and Greg Garfield, who serves as Senior Managing Director with KCK-US, Inc., an affiliate of KCK Ltd., are also members of our board of directors.
  • [F3]Each share of Preferred Stock automatically converted on a 1-for-1 basis into Common Stock upon the closing of the Issuer's initial public offering, for no additional consideration. The Preferred Stock has no expiration date.

Issuer

NeuroPace Inc

CIK 0001528287

Entity typeother

Related Parties

1
  • filerCIK 0001594406

Filing Metadata

Form type
4
Filed
Apr 25, 8:00 PM ET
Accepted
Apr 26, 5:17 PM ET
Size
16.6 KB